Phase II Pilot Study of Brentuximab Vedotin, Rituximab and Dose Attenuated CHP in Elderly Patients with DLBCL

IRB/UVA Tracking #
19731
Contact First Name

Erica Stallard

Contact Email
Phase
II
Primary purpose
Treatment
Cancer PI
Craig Portell
Status
OPEN TO ACCRUAL